The Royal Marsden launches world’s first fully integrated multiple myeloma patient pathway
The Royal Marsden has announced the launch of MyTrack Myeloma, the world’s first fully integrated patient pathway for multiple myeloma. This innovative, patient-centred approach brings together leading-edge innovation in advanced diagnostics […]
University of Warwick research warns that popular deep learning systems trained for cancer pathology may be relying on hidden shortcuts rather than genuine biological signals.
Artificial intelligence tools are increasingly being developed to predict cancer biology directly from microscope images, promising faster diagnoses, and cheaper testing. But new research from the University of Warwick, published in Nature […]
The role of ctDNA in oncology: Faster diagnosis and personalised care
By Dr Angela George, Consultant Medical Oncologist and Consultant in Oncogenetics at The Royal Marsden As oncologists, we owe it to every patient to give them the best possible treatment […]
The Royal Marsden GI Updates in Oesophagogastric Cancers
We will focus on the latest evidence base in the managements of these aggressive cancers, surgical and oncological considerations, and technological advances. The participants will leave the meeting with clear […]
